Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
NP
|
John P O'Donnell
President and CEO |
SELL
Open market or private sale
|
Direct | 4,201 Reduced 4.69% |
$392,794
$93.5 p/Share
|
Jan 16
2018 |
NP
|
John P O'Donnell
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 4,201 Added 4.48% |
$250,884
$59.72 p/Share
|
Jan 16
2018 |
CORI
|
Perceptive Advisors LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 50,350 Added 0.85% |
$595,640
$11.83 p/Share
|
Jan 16
2018 |
AFSI
|
Stephen Ungar
SVP, GC and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 200 Added 0.12% |
$1,154
$5.77 p/Share
|
Jan 16
2018 |
MSF
|
City Of London Investment Group PLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 10,400 Added 5.68% |
$196,352
$18.88 p/Share
|
Jan 16
2018 |
IIF
|
City Of London Investment Group PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 2,206 Reduced 0.55% |
$75,886
$34.4 p/Share
|
Jan 16
2018 |
CHN
|
City Of London Investment Group PLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 13,008 Added 3.55% |
$299,964
$23.06 p/Share
|
Jan 16
2018 |
AXS
|
Michael A Butt
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7,082 Added 0.72% |
-
|
Jan 16
2018 |
AXS
|
Charles A Davis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,653 Added 33.92% |
-
|
Jan 16
2018 |
AXS
|
Robert L. Friedman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,451 Added 6.99% |
-
|
Jan 16
2018 |
AXS
|
Maurice A Keane
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,375 Added 4.05% |
-
|
Jan 16
2018 |
AXS
|
Cheryl Ann Lister
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,552 Added 13.49% |
-
|
Jan 16
2018 |
AXS
|
Henry B Smith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,046 Added 7.4% |
-
|
Jan 16
2018 |
AXS
|
Wilhelm Zeller
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,451 Added 25.24% |
-
|
Jan 16
2018 |
CHCO
|
Robert D Fisher
Director |
BUY
Open market or private purchase
|
Direct | 162 Added 0.54% |
$11,406
$70.41 p/Share
|
Jan 16
2018 |
CHCO
|
Tracy W Hylton Ii
Director |
BUY
Open market or private purchase
|
Direct | 140 Added 0.31% |
$9,857
$70.41 p/Share
|
Jan 16
2018 |
AMGN
|
Sean E Harper
EVP, Research & Development |
SELL
Open market or private sale
|
Direct | 1,525 Reduced 2.71% |
$283,070
$185.62 p/Share
|
Jan 16
2018 |
ORCL
|
Hector Garcia Molina
Director |
SELL
Open market or private sale
|
Direct | 3,750 Reduced 18.75% |
$186,450
$49.72 p/Share
|
Jan 16
2018 |
ORCL
|
Hector Garcia Molina
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 3,750 Added 15.79% |
$79,575
$21.22 p/Share
|
Jan 16
2018 |
ORCL
|
Safra Catz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 450,847 Reduced 43.44% |
$22,546,858
$50.01 p/Share
|
Jan 16
2018 |
ORCL
|
Safra Catz
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 450,847 Added 30.28% |
$9,485,821
$21.04 p/Share
|
Jan 16
2018 |
FFBC
|
J Wickliffe Ach
Director |
BUY
Open market or private purchase
|
Direct | 96 Added 1.93% |
$2,707
$28.2 p/Share
|
Jan 16
2018 |
FFBC
|
David S Barker
Director |
BUY
Open market or private purchase
|
Direct | 333 Added 3.09% |
$9,391
$28.2 p/Share
|
Jan 16
2018 |
FFBC
|
Cynthia O Booth
Director |
BUY
Open market or private purchase
|
Direct | 197 Added 3.33% |
$5,555
$28.2 p/Share
|
Jan 16
2018 |
FFBC
|
Corinne R Finnerty
Director |
BUY
Open market or private purchase
|
Direct | 224 Added 1.14% |
$6,317
$28.2 p/Share
|
Jan 16
2018 |
FFBC
|
Knapke Murph
Director |
BUY
Open market or private purchase
|
Direct | 196 Added 1.89% |
$5,527
$28.2 p/Share
|
Jan 16
2018 |
FFBC
|
Knust Susan L Purkrabek
Director |
BUY
Open market or private purchase
|
Direct | 203 Added 1.75% |
$5,725
$28.2 p/Share
|
Jan 16
2018 |
FFBC
|
William J Kramer
Director |
BUY
Open market or private purchase
|
Direct | 96 Added 1.97% |
$2,707
$28.2 p/Share
|
Jan 16
2018 |
FFBC
|
Jeffrey D Meyer
Director |
BUY
Open market or private purchase
|
Direct | 297 Added 6.41% |
$8,375
$28.2 p/Share
|
Jan 16
2018 |
FFBC
|
John T Neighbours
Director |
BUY
Open market or private purchase
|
Direct | 287 Added 9.4% |
$8,093
$28.2 p/Share
|
Jan 16
2018 |
FFBC
|
Richard E Olszewski
Director |
BUY
Open market or private purchase
|
Direct | 269 Added 1.78% |
$7,586
$28.2 p/Share
|
Jan 16
2018 |
FFBC
|
Maribeth S Rahe
Director |
BUY
Open market or private purchase
|
Direct | 341 Added 2.8% |
$9,616
$28.2 p/Share
|
Jan 16
2018 |
S
|
Softbank Group Corp
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,029,321 Added 0.09% |
$17,145,956
$5.66 p/Share
|
Jan 16
2018 |
BATL
|
Franklin Resources Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 450,000 Reduced 1.31% |
$3,888,000
$8.64 p/Share
|
Jan 16
2018 |
PCF
|
Bulldog Investors, LLP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 10,500 Added 0.82% |
$95,655
$9.11 p/Share
|
Jan 16
2018 |
WHG
|
Julie Kramer Gerron
General Counsel & CCO |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.78% |
$34,315
$68.63 p/Share
|
Jan 16
2018 |
AROW
|
Raymond F O'Conor
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.0% |
$17,175
$34.35 p/Share
|
Jan 16
2018 |
MRK
|
Michael J Holston
EVP, General Counsel |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 20.29% |
$770,375
$61.63 p/Share
|
Jan 16
2018 |
MRK
|
Adam H Schechter
EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Direct | 50,994 Reduced 100.0% |
$3,142,760
$61.63 p/Share
|
Jan 16
2018 |
MRK
|
Adam H Schechter
EVP & Pres-Global Human Health |
BUY
Exercise of conversion of derivative security
|
Direct | 50,994 Added 50.0% |
$1,864,341
$36.56 p/Share
|
Jan 16
2018 |
MRK
|
Adam H Schechter
EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Indirect | 50,608 Reduced 44.64% |
$3,118,971
$61.63 p/Share
|
Jan 16
2018 |
MRK
|
Weir Mirian M Graddick
Exe V-P, HR |
BUY
Exercise of conversion of derivative security
|
Direct | 52,000 Added 25.31% |
$2,303,600
$44.3 p/Share
|
Jan 16
2018 |
MRK
|
Weir Mirian M Graddick
Exe V-P, HR |
SELL
Open market or private sale
|
Direct | 60,000 Reduced 39.09% |
$3,697,800
$61.63 p/Share
|
Jan 16
2018 |
CINF
|
Thomas R Schiff |
SELL
Bona fide gift
|
Indirect | 42,855 Reduced 9.86% |
-
|
Jan 15
2018 |
GABC
|
Christina M Ernst |
BUY
Open market or private purchase
|
Indirect | 20 Added 0.04% |
$741
$37.04 p/Share
|
Jan 15
2018 |
GABC
|
U Butch Klem |
BUY
Open market or private purchase
|
Direct | 56 Added 0.03% |
$2,074
$37.04 p/Share
|
Jan 15
2018 |
GABC
|
Chris A Ramsey |
BUY
Open market or private purchase
|
Direct | 18 Added 0.11% |
$667
$37.04 p/Share
|
Jan 15
2018 |
GABC
|
Raymond Ward Snowden |
BUY
Open market or private purchase
|
Indirect | 37 Added 0.14% |
$1,370
$37.04 p/Share
|
Jan 15
2018 |
GABC
|
Michael J Voyles |
BUY
Open market or private purchase
|
Direct | 18 Added 0.02% |
$667
$37.04 p/Share
|
Jan 15
2018 |
GABC
|
Douglas A Bawel |
BUY
Open market or private purchase
|
Indirect | 18 Added 0.03% |
$667
$37.04 p/Share
|
Jan 15
2018 |